Chief Scientific Officer @ (February 2023 - August 2023)
Chief Scientific Officer @ Epizyme (April 2020 - September 2022)
Chief Scientific Officer @ (February 2017 - March 2020)
Vice President, Biology and Translational Science @ (August 2013 - February 2017)
Senior Director, Biology and Translational Research @ (August 2012 - August 2013)
Senior Director, Molecular Pathology @ (March 2012 - July 2012)
Director, Molecular Pathology @ (December 2010 - March 2012)
Associate Professor of Pathology @ Brigham and Women's Hospital, Harvard Medical School (January 2005 - December 2010)
Assistant Professor of Pathology @ Brigham and Women's Hospital, Harvard Medical School (January 2002 - December 2005)
Instructor in Pathology @ Brigham and Women's Hospital, Harvard Medical School (January 1998 - December 2002)
Hematopathology Fellow @ Brigham and Women's Hospital, Harvard Medical School (July 1997 - December 1998)
Anatomic Pathology Resident @ Brigham and Women's Hospital, Harvard Medical School (July 1995 - July 1997)
Jeff Kutok Education
State University of New York at Stony Brook
Doctor of Philosophy (Ph.D.) (Molecular and Cellular Pathology)
1988-1995
Stony Brook University Health Sciences Center School of Medicine
Doctor of Medicine (M.D.)
1988-1995
Jeff Kutok Skills
Laboratory
Immunohistochemistry
Biology
Molecular Pathology
Marketing
Immunology
Drug Discovery
Molecular Biology
Lifesciences
Customer Service
Immuno Oncology
Life Sciences
Translational Medicine
Drug Development
Cell Biology
Biomarkers
Cancer
Clinical Development
Biomarker Development
Clinical Trials
Biotechnology
Pathology
Translational Research
Preclinical Development
Clinical Research
Biomarker Discovery
Project Management
Medicine
Pharmacology
Pharmaceutical Industry
Personalized Medicine
Strategic Planning
Board Certified
Oncology
Healthcare
Leadership
Laboratory Skills
Training
Data Analysis
Jeff Kutok Summary
Jeff Kutok, based in Waltham, MA, US, is currently a Chief Scientific Officer at Ensem Therapeutics. Jeff Kutok brings experience from previous roles at 4:59 NewCo, a 5AM Ventures Company, Epizyme and Infinity Pharmaceuticals. Jeff Kutok holds a 1988 - 1995 Doctor of Philosophy (Ph.D.) in Molecular and Cellular Pathology @ State University of New York at Stony Brook. With a robust skill set that includes Laboratory, Immunohistochemistry, Biology, Molecular Pathology, Marketing and more. Jeff Kutok has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jeff Kutok?
Find contact details for 700 million professionals.